<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02824107</url>
  </required_header>
  <id_info>
    <org_study_id>Béjot PARI 2015</org_study_id>
    <nct_id>NCT02824107</nct_id>
  </id_info>
  <brief_title>Psychosocial Risk Factors in Stroke and Myocardial Infarction</brief_title>
  <acronym>INEV@L</acronym>
  <official_title>INEqualities in Health Psychosocial Determinants of Neuro and Cardio-V@scuLar Disease: Identification of Novel Levers for Secondary Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      The aim of this study is to identify groups of subjects at risk of recurrence in secondary
      prevention based on Psychosocial Factors.

      The aim is also to propose novel levers to reduce health inequalities in this population so
      as to develop new prevention strategies for neuro- and cardio-vascular health This study is
      based on data from questionnaires (Quality of life at work, perceived stress, perceived
      disease severity) and on behavior indicators (factors related to lifestyle: alcohol, smoking,
      obesity, sedentarity).

      Biomarkers of endothelial function (ADMA) will also be assayed. It's an interventional study
      because of blood sample
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 2016</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of psychosocial factors (PSF) on the level of risk for neuro-cardiovascular disease.</measure>
    <time_frame>through the completion study an average of 6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>study the proportion of diméthyl-arginine asymetrical (ADMA) in patients with PSF</measure>
    <time_frame>1st day</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Myocardial Infarction</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>patients with myocardial infarction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <arm_group_label>patients with myocardial infarction</arm_group_label>
    <arm_group_label>patients with stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>questionnaires for psychosocial factors</intervention_name>
    <arm_group_label>patients with myocardial infarction</arm_group_label>
    <arm_group_label>patients with stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided oral consent to participate

          -  Patients over 18 years

          -  Patients hospitalized for type 1 MI or ischemic stroke/TIA &lt; 24H after symptom onset

          -  Age &lt; 65 years

          -  With a professional activity (INSEE definition) at the time of the neuro or
             cardiovascular event

          -  At least one of the following risk factors: current smoking, obesity (waist
             circumference &gt; 88 cm (W)/102 cm (M) or a waist/hip ratio 0.85(W)/0.9(M), sedentarity
             (physical activity &lt; 150 min / week), alcohol consumption (&gt; 3 standard glasses per
             day for men, &gt; 2 standard glasses/d for women)

        Exclusion Criteria:

          -  Adult under guardianship

          -  Patients without national health insurance cover

          -  Pregnant or breast-feeding women

          -  Clinical state making it impossible to use questionnaires or to measure risk factors

          -  Stroke or TIA not related to atheroma or cardioembolism (dissection, hemopathy…)

          -  type &gt; 1 MI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yannick BEJOT</last_name>
    <phone>3 80.29.37.53</phone>
    <phone_ext>+33</phone_ext>
    <email>yannick.bejot@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick BEJOT</last_name>
      <phone>3 80.29.37.53</phone>
      <phone_ext>+33</phone_ext>
      <email>yannick.bejot@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2016</study_first_submitted>
  <study_first_submitted_qc>July 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <last_update_submitted>October 9, 2017</last_update_submitted>
  <last_update_submitted_qc>October 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

